296 related articles for article (PubMed ID: 22564513)
41. Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate.
Funk C; Pantze M; Jehle L; Ponelle C; Scheuermann G; Lazendic M; Gasser R
Toxicology; 2001 Oct; 167(1):83-98. PubMed ID: 11557132
[TBL] [Abstract][Full Text] [Related]
42. The bile salt export pump: molecular properties, function and regulation.
Arrese M; Ananthanarayanan M
Pflugers Arch; 2004 Nov; 449(2):123-31. PubMed ID: 15578267
[TBL] [Abstract][Full Text] [Related]
43. Basal efflux of bile acids contributes to drug-induced bile acid-dependent hepatocyte toxicity in rat sandwich-cultured hepatocytes.
Susukida T; Sekine S; Ogimura E; Aoki S; Oizumi K; Horie T; Ito K
Toxicol In Vitro; 2015 Oct; 29(7):1454-63. PubMed ID: 26055650
[TBL] [Abstract][Full Text] [Related]
44. The feline bile salt export pump: a structural and functional comparison with canine and human Bsep/BSEP.
van Beusekom CD; van den Heuvel JJ; Koenderink JB; Schrickx JA; Russel FG
BMC Vet Res; 2013 Dec; 9():259. PubMed ID: 24359682
[TBL] [Abstract][Full Text] [Related]
45. Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells.
He H; Mennone A; Boyer JL; Cai SY
Hepatology; 2011 Feb; 53(2):548-57. PubMed ID: 21274875
[TBL] [Abstract][Full Text] [Related]
46. Degradation of the bile salt export pump at endoplasmic reticulum in progressive familial intrahepatic cholestasis type II.
Wang L; Dong H; Soroka CJ; Wei N; Boyer JL; Hochstrasser M
Hepatology; 2008 Nov; 48(5):1558-69. PubMed ID: 18798335
[TBL] [Abstract][Full Text] [Related]
47. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
Stindt J; Ellinger P; Weissenberger K; Dröge C; Herebian D; Mayatepek E; Homey B; Braun S; Schulte am Esch J; Horacek M; Canbay A; Schmitt L; Häussinger D; Kubitz R
Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
[TBL] [Abstract][Full Text] [Related]
48. Taurine supplementation induces multidrug resistance protein 2 and bile salt export pump expression in rats and prevents endotoxin-induced cholestasis.
Mühlfeld A; Kubitz R; Dransfeld O; Häussinger D; Wettstein M
Arch Biochem Biophys; 2003 May; 413(1):32-40. PubMed ID: 12706339
[TBL] [Abstract][Full Text] [Related]
49. De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis.
Keitel V; Burdelski M; Vojnisek Z; Schmitt L; Häussinger D; Kubitz R
Hepatology; 2009 Aug; 50(2):510-7. PubMed ID: 19642168
[TBL] [Abstract][Full Text] [Related]
50. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity.
Yu J; Lo JL; Huang L; Zhao A; Metzger E; Adams A; Meinke PT; Wright SD; Cui J
J Biol Chem; 2002 Aug; 277(35):31441-7. PubMed ID: 12052824
[TBL] [Abstract][Full Text] [Related]
51. Role of the bile salt export pump, BSEP, in acquired forms of cholestasis.
Stieger B
Drug Metab Rev; 2010 Aug; 42(3):437-45. PubMed ID: 20028269
[TBL] [Abstract][Full Text] [Related]
52. Transcriptional dynamics of bile salt export pump during pregnancy: mechanisms and implications in intrahepatic cholestasis of pregnancy.
Song X; Vasilenko A; Chen Y; Valanejad L; Verma R; Yan B; Deng R
Hepatology; 2014 Dec; 60(6):1993-2007. PubMed ID: 24729004
[TBL] [Abstract][Full Text] [Related]
53. Dan-shen Yin promotes bile acid metabolism and excretion to prevent atherosclerosis via activating FXR/BSEP signaling pathway.
Sheng Y; Meng G; Zhang M; Chen X; Chai X; Yu H; Han L; Wang Q; Wang Y; Jiang M
J Ethnopharmacol; 2024 Aug; 330():118209. PubMed ID: 38663779
[TBL] [Abstract][Full Text] [Related]
54. Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy.
Vallejo M; Briz O; Serrano MA; Monte MJ; Marin JJ
J Hepatol; 2006 Jun; 44(6):1150-7. PubMed ID: 16458994
[TBL] [Abstract][Full Text] [Related]
55. Modeling Human Bile Acid Transport and Synthesis in Stem Cell-Derived Hepatocytes with a Patient-Specific Mutation.
Hayashi H; Osaka S; Sakabe K; Fukami A; Kishimoto E; Aihara E; Sabu Y; Mizutani A; Kusuhara H; Naritaka N; Zhang W; Huppert SS; Sakabe M; Nakamura T; Hu YC; Mayhew C; Setchell K; Takebe T; Asai A
Stem Cell Reports; 2021 Feb; 16(2):309-323. PubMed ID: 33450190
[TBL] [Abstract][Full Text] [Related]
56. Defects in myosin VB are associated with a spectrum of previously undiagnosed low γ-glutamyltransferase cholestasis.
Qiu YL; Gong JY; Feng JY; Wang RX; Han J; Liu T; Lu Y; Li LT; Zhang MH; Sheps JA; Wang NL; Yan YY; Li JQ; Chen L; Borchers CH; Sipos B; Knisely AS; Ling V; Xing QH; Wang JS
Hepatology; 2017 May; 65(5):1655-1669. PubMed ID: 28027573
[TBL] [Abstract][Full Text] [Related]
57. Generation of a bile salt export pump deficiency model using patient-specific induced pluripotent stem cell-derived hepatocyte-like cells.
Imagawa K; Takayama K; Isoyama S; Tanikawa K; Shinkai M; Harada K; Tachibana M; Sakurai F; Noguchi E; Hirata K; Kage M; Kawabata K; Sumazaki R; Mizuguchi H
Sci Rep; 2017 Feb; 7():41806. PubMed ID: 28150711
[TBL] [Abstract][Full Text] [Related]
58. Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2.
Maggiore G; Gonzales E; Sciveres M; Redon MJ; Grosse B; Stieger B; Davit-Spraul A; Fabre M; Jacquemin E
J Hepatol; 2010 Nov; 53(5):981-6. PubMed ID: 20800306
[TBL] [Abstract][Full Text] [Related]
59. Benign recurrent intrahepatic cholestasis associated with mutations of the bile salt export pump.
Kubitz R; Keitel V; Scheuring S; Köhrer K; Häussinger D
J Clin Gastroenterol; 2006 Feb; 40(2):171-5. PubMed ID: 16394881
[TBL] [Abstract][Full Text] [Related]
60. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids.
Zollner G; Wagner M; Moustafa T; Fickert P; Silbert D; Gumhold J; Fuchsbichler A; Halilbasic E; Denk H; Marschall HU; Trauner M
Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G923-32. PubMed ID: 16357057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
